The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 332:328-329 February 2, 1995 Number 5
NextNext

Can Lowering Homocysteine Levels Reduce Cardiovascular Risk?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
High serum cholesterol levels are an important risk factor for coronary disease, but most patients with myocardial infarction have normal cholesterol levels. Despite considerable advances in our understanding of the causes of cardiovascular disease, the established risk factors cannot fully explain its occurrence. The article by Selhub and colleagues1 in this issue of the Journal contributes importantly to the rapidly accumulating evidence that elevated blood levels of homocysteine increase the risk of vascular disease.

The original hypothesis, proposed by McCully,2 was based on postmortem findings of arteriosclerotic disease in patients with extraordinarily high blood homocysteine levels due to rare metabolic . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.